Findings

What do systematic reviews say?

13 questions · 13 findings · 2 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 6 · 46.2%Very low 2 · 15.4%Low 1 · 7.7%Moderate 0 · 0%High 4 · 30.8%

Rosuvastatin vs placebo

Time to heart decompensation · chronic heart failure in Chagas cardiomyopathy patients

1 finding from 1 review

Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
GRADE not reported

Rosuvastatin vs placebo

Disease‐free period at 30, 60 and 90 days · chronic heart failure in Chagas cardiomyopathy patients

1 finding from 1 review

Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
GRADE not reported

Rosuvastatin vs placebo

Quality of life · chronic heart failure in Chagas cardiomyopathy patients

1 finding from 1 review

Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Very low

Rosuvastatin vs placebo

Adverse events · chronic heart failure in Chagas cardiomyopathy patients

1 finding from 1 review

Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
GRADE not reported

Rosuvastatin vs placebo

Hospital readmissions (heart failure‐ or adverse event‐related) · chronic heart failure in Chagas cardiomyopathy patients

1 finding from 1 review

Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
GRADE not reported

Rosuvastatin vs placebo

All‐cause mortality · chronic heart failure in Chagas cardiomyopathy patients

1 finding from 1 review

Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
GRADE not reported

Rosuvastatin vs placebo

Cardiac mortality · chronic heart failure in Chagas cardiomyopathy patients

1 finding from 1 review

Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
GRADE not reported

Intervention not reported

LDL‐Cholesterol rosuvastatin 2.5 mg/day · participantswith normal or abnormal lipid profiles

1 finding from 1 review

Rosuvastatin for lowering lipids 2014 · Cochrane Headline outcomes only
no estimate extracted
11 studies · 450 participants
Low

Intervention not reported

LDL‐Cholesterol rosuvastatin 5 mg/day · participantswith normal or abnormal lipid profiles

1 finding from 1 review

Rosuvastatin for lowering lipids 2014 · Cochrane Headline outcomes only
no estimate extracted
25 studies · 2602 participants
High

Intervention not reported

LDL‐Cholesterol rosuvastatin 10 mg/day · participantswith normal or abnormal lipid profiles

1 finding from 1 review

Rosuvastatin for lowering lipids 2014 · Cochrane Headline outcomes only
no estimate extracted
74 studies · 9855 participants
High

Intervention not reported

LDL‐Cholesterol rosuvastatin 20 mg/day · participantswith normal or abnormal lipid profiles

1 finding from 1 review

Rosuvastatin for lowering lipids 2014 · Cochrane Headline outcomes only
no estimate extracted
28 studies · 3675 participants
High

Intervention not reported

LDL‐Cholesterol rosuvastatin 40 mg/day · participantswith normal or abnormal lipid profiles

1 finding from 1 review

Rosuvastatin for lowering lipids 2014 · Cochrane Headline outcomes only
no estimate extracted
18 studies · 3512 participants
High

Intervention not reported

WDAE2 all doses · participantswith normal or abnormal lipid profiles

1 finding from 1 review

Rosuvastatin for lowering lipids 2014 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 1330 participants
Very low